Analysis of the tumor microenvironment revealed a shift toward a pro-inflammatory state, characterized by an increased CD8+/CD4+ T-cell–to–macrophage/MDSC ratio, reduced intratumoral TGF-β levels, and enhanced proliferation and activation of CD4+ and CD8+ T cells (52). The gene discussed is CD4; the disease is neoplasm.